Cargando…
Fecal Tests: From Blood to Molecular Markers
Detection of molecular markers for colorectal neoplasia in feces has the potential to improve performance of simple noninvasive screening tests for colorectal cancer. Most research has explored the value of DNA-based, RNA-based, and protein-based markers. In all cases there has been a trend to move...
Autores principales: | Young, Graeme P., Bosch, Linda J. W. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Current Science Inc.
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3029665/ https://www.ncbi.nlm.nih.gov/pubmed/21423316 http://dx.doi.org/10.1007/s11888-010-0084-8 |
Ejemplares similares
-
Advances in Fecal Occult Blood Tests: The FIT Revolution
por: Young, Graeme P., et al.
Publicado: (2014) -
Fecal Molecular Markers for Colorectal Cancer Screening
por: Kanthan, Rani, et al.
Publicado: (2012) -
Harms, benefits and costs of fecal immunochemical testing versus guaiac fecal occult blood testing for colorectal cancer screening
por: Goede, S. Lucas, et al.
Publicado: (2017) -
The Impact of Transitioning From Guaiac-Fecal Occult Blood Testing to Fecal Immunochemical Testing in a Canadian Colon Cancer Screening Program
por: Sultanian, Richard, et al.
Publicado: (2020) -
A Blood Test for Methylated BCAT1 and IKZF1 vs. a Fecal Immunochemical Test for Detection of Colorectal Neoplasia
por: Symonds, Erin L, et al.
Publicado: (2016)